Vivakor, Inc. VIVK
Nasdaq · XNAS · stock · Refuse Systems
Chart by TradingView
4/9
Piotroski F — financial health
-12.16
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $104.4M | -$110.2M | $37.7M | — | $41.3M |
| 2024 | $89.8M | -$26.4M | $10.2M | — | $115.1M |
| 2023 | $59.3M | -$10.8M | $5.0M | -$4.1M | $17.2M |
| 2022 | $28.1M | -$20.2M | $2.9M | -$6.6M | $27.1M |
| 2021 | $1.1M | -$7.3M | $37,752 | -$7.1M | $27.6M |
| 2020 | $1.5M | -$2.9M | $101,403 | -$3.0M | $16.7M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Hawley Kimberly Ann | CFO | 2025-11-26 | Grant | 25,000 | $0.13 |
| Ballengee James H. | CEO | 2025-11-10 | J | 2,979,456 | $0.17 |
| Ballengee James H. | CEO | 2025-11-10 | J | 30,096 | $0.17 |
| Ballengee James H. | Chairman, President, & CEO | 2024-12-02 | Grant | 369,740 | $0.60 |
| Ballengee James H. | Chairman, President, & CEO | 2024-12-02 | Grant | 4,999,500 | $1.00 |
| Ballengee James H. | Chairman, President, & CEO | 2024-12-02 | Grant | 50,500 | $1.00 |
| Knapp Patrick | EVP, Gen. Counsel, & Secretary | 2024-07-03 | Grant | 140,190 | $1.78 |
| Ballengee James H. | Chairman, President, & CEO | 2024-06-18 | Grant | 422,199 | $0.59 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -12.16 (distress)
- Working capital / assets -0.47
- Retained earnings / assets -1.8
- EBIT / assets -0.562
- Equity / liabilities 0.541
Source: SEC EDGAR filings · CIK 0001450704 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.